The FDA has granted Fast Track Designation to Lundbeck’s investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA). Lundbeck has recently initiated ...
The FDA has granted Fast Track Designation to Lundbeck's investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA).
Three of America’s top milk-producing states are not participating in the U.S. Department of Agriculture’s program designed ...
(PRESS RELEASE) ROCHESTER, N.Y. — CooperVision announced a series of investments designed to reinforce its worldwide leadership in myopia management, including actions to further bolster commercial ...
Can supplementing with vitamins and minerals protect your eye health? Learn more about the role of nutrients in age-related ...
Monumental Sports and Entertainment announced Monday that tickets are now available for the live ice skating tribute to honor ...